Piramal plans to buy ailing biotechs; Pfizer nixes hopes for sweetened Icagen bid; Aura BioSciences raises about $3M;

@FierceBiotech: Study: Less than 1% of cancer patients enrolled in a clinical trial. Piece Very troubling. | Follow @FierceBiotech

@JohnCFierce: 52% of hospital/pharmacy purchasing agents bought drugs from gray market vendors in past 2 years. Price gouging? Article | Follow @JohnCFierce

@RyanMFierce: I have to think Medtronic folks are scrambling in the wake of the storm created by the insulin-pump hacker's report Story $MDT | Follow @RyanMFierce

@MaureenFierce: FDA issues dire warning after personal massage device kills a patient. Report | Follow @MaureenFierce

> Indian drug developer Piramal says it plans to spend up to $1.5 billion buying ailing mid-sized biotechs in the U.S. and Europe. Story

> Pfizer says it simply isn't interested in paying any more than $6 a share to acquire Icagen, even if its bid doesn't succeed in spurring shareholders to tender more than half of the shares. A number of investors have balked at the offer, saying the bid undervalues the biotech. Report

> The nanotech drug delivery company Aura Biosciences has raised nearly $3 million in a new round. Story

> Germany's AiCuris says the FDA has granted fast track status to its HCMV drug letermovir (AIC246). AiCuris release

> Tekmira Pharmaceuticals has acquired an exclusive worldwide license to RNAi technology from Halo-Bio. Tekmira release

Pharma News

 @FiercePharma: Piramal sold off its generics biz to Abbott. Now, founder wants to grow overseas via $1.5B in deals. Item $ABT | Follow @FiercePharma

> Pfizer/BMS clot drug expected to best Pradaxa, Xarelto. Article

Biotech IT News

> Alzheimer's trial database finds takers in W. Florida. More

> NexDocs opens the door to VC with $10.3M funding. Report

> Case Western spinoff wins NIH grant for software. News

> China a new frontier for growing clinical tech firm. Article

> Report: Samsung to test genetic analysis service. Details

> NIH pumping $25M to link EMR info to genetic data. Story

Medical Device News

> Abbott Molecular, Pfizer get nod for drug, companion Dx. Details

> Yates to head EMD Millipore. News

> Medtronic sees positive results with CoreValve. Article

And Finally... A new study finds that there's a lot of truth in the old saying about laughter being the best medicine. Researchers say laughing helps the body's vascular system, just as mental stress can damage it. Release